EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach-Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial-Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider-Stock iD

Molecular Oncology · 2026

DOI: 10.1002/1878-0261.70150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2026. Verfasst von Arnatchai Maiuthed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase Inhibitor p21, Neoplastic Stem Cells, NF-kappa B, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexander von Humboldt-Stiftung THA-IP, Mahidol University (Basic Research Fund: fiscal year 2021), Alexander von Humboldt-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) drive tumor initiation, metastasis, and therapy resistance. The role of cytoplasmic cyclin‐dependent kinase inhibitor 1A (CDKN1A, p21) in CSC biology remains unclear. Since cytoplasmic p21 correlated with advanced stage and metastasis in colorectal cancer (CRC) patients, we investigated its causal role in CSC features in vitro and in vivo . Cytoplasmic p21 increased spheroid formation and CD133 expression in a mechanism partly dependent on AKT activation. Phosphomimetic p21 (p21 T145D ) enhanced spheroid growth, CD133, and stemness factors (Oct3/4, Nanog, Sox2), whereas nuclear p21 (p21 T145A ) reduced them. Immunoprecipitation, proximity ligation assays, and in silico modeling demonstrated that cytoplasmic p21 interacts with the NFκB–IκB complex, promoting NFκB release and activation. Consequently, NFκB targets BCL‐xL and COX2 were upregulated in p21 T145D ‐ and AKT T308D,S473D CRC cells in vitro and in a chorioallantoic membrane (CAM) model, supporting their role as downstream effectors of cytoplasmic p21. Our findings uncover a new function of cytoplasmic p21 in regulating CSC properties through NFκB modulation. Screening p21 subcellular localization may stratify CRC patients with high metastatic risk providing a basis for CSC‐targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase Inhibitor p21Neoplastic Stem CellsNF-kappa BColonic NeoplasmsCytoplasmSignal TransductionHumansCell Line, TumorAnimalsSpheroids, CellularMice

Stichwörter der Autor:innen

BCL‐xLCAM modelCD133IκBNFκBstem cells

Substanzen

Cyclin-Dependent Kinase Inhibitor p21NF-kappa BCDKN1A protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Centre of Biopharmaceutical Science for Healthy Ageing, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Department of Experimental Tumor Pathology, Universitätsklinikum, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Institute of Pathology, Universitätsklinikum, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Department of Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
  • Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Regine Schneider-Stock

Förderung

  • Alexander von Humboldt-Stiftung THA-IP
  • Mahidol University (Basic Research Fund: fiscal year 2021)
  • Alexander von Humboldt-Stiftung
  • Faculty of Science, Mahidol University

Zitieren

APA

Maiuthed, A., Huebner, K., Erlenbach-Wuensch, K., Hampel, C., Thalheim, D., Vial-Roehe, A., Nutho, B., Merkel, S., Hartmann, A., Chanvorachote, P., & Schneider-Stock, R. (2026). Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway. Molecular Oncology. https://doi.org/10.1002/1878-0261.70150

Vancouver

Maiuthed A, Huebner K, Erlenbach-Wuensch K, Hampel C, Thalheim D, Vial-Roehe A, et al. Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway. Molecular Oncology. 2026. doi:10.1002/1878-0261.70150

BibTeX
@article{Maiuthed2026,
  author = {Maiuthed, Arnatchai and Huebner, Kerstin and Erlenbach-Wuensch, Katharina and Hampel, Chuanpit and Thalheim, Daniela and Vial-Roehe, Adriana and Nutho, Bodee and Merkel, Susanne and Hartmann, Arndt and Chanvorachote, Pithi and Schneider-Stock, Regine},
  title = {Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway},
  journal = {Molecular Oncology},
  year = {2026},
  doi = {10.1002/1878-0261.70150}
}
Kostenlos starten →